Actively Recruiting
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
Led by University Heart Center Freiburg - Bad Krozingen · Updated on 2026-04-07
600
Participants Needed
4
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying adults hospitalized with acute heart failure and cardiogenic shock to understand if routine hospital care information, along with blood and urine samples, can help doctors better classify types of cardiogenic shock and predict patient outcomes. The study aims to see if clinical findings, imaging, and biomarkers, including those specific to sex, relate to the risk of death within 30 days. This observational study does not involve experimental treatments but focuses on data collection and analysis. Participants will have data collected from their routine hospital care, plus additional blood and urine samples will be taken for biobanking. The study will follow patients after hospital discharge to collect further information. There are no assigned treatment groups since this is an observational study. During the study, researchers will monitor outcomes such as death within 30 days, as well as rehospitalization for heart failure or other cardiac reasons up to 12 months after discharge. Data collected includes clinical details, imaging, and biomarker information. Participants' usual care continues throughout, with no additional treatment assigned. The total study participation involves follow-up after hospital discharge and sample collection during hospitalization.
CONDITIONS
Brief Title
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized with acute heart failure SCAI stage B - E
You will not qualify if you...
- Not capable of providing informed consent due to reasons not attributable to cardiogenic shock
- Cardiogenic shock following cardiothoracic surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - During hospitalization
Participants undergo detailed assessments to characterize their acute cardiac failure condition.
1 to 2 visits during hospital stay
Duration - Up to 12 months after hospital discharge
Participants are observed to track mortality and rehospitalization outcomes over time.
Periodic follow-up contacts up to 12 months
Trial Site Locations
Total: 4 locations
1
University Heart Center Freiburg - Bad Krozingen
Bad Krozingen, Germany, 79189
Actively Recruiting
2
University Medical Center Freiburg, Interdisciplinary Medical Intensive Care
Freiburg im Breisgau, Germany, 79106
Actively Recruiting
3
Department for Internal Medicine 8, Clinic for Cardiology and Rhythmology, University Clinic of the Paracelsus Medi-cal University Nuremberg
Nuremberg, Germany
Active, Not Recruiting
4
Schwarzwald Baar Klinikum Villingen-Schwenningen, Klinik für Kardiologie und Intensivmedizin
Villingen-Schwenningen, Germany
Actively Recruiting
Research Team
L
Lucas Bacmeister, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here